Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26,475,256
-
Number of holders
-
79
-
Total 13F shares, excl. options
-
7,684,503
-
Shares change
-
+646,005
-
Total reported value, excl. options
-
$40,650,943
-
Value change
-
+$2,876,265
-
Put/Call ratio
-
39.57%
-
Number of buys
-
42
-
Number of sells
-
-35
-
Price
-
$5.29
Significant Holders of AVITA Medical, Inc. - Common Stock (RCEL) as of Q2 2025
96 filings reported holding RCEL - AVITA Medical, Inc. - Common Stock as of Q2 2025.
AVITA Medical, Inc. - Common Stock (RCEL) has 79 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7,684,503 shares
of 26,475,256 outstanding shares and own 29.03% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (1,895,655 shares), VANGUARD GROUP INC (1,450,367 shares), GEODE CAPITAL MANAGEMENT, LLC (618,342 shares), STATE STREET CORP (528,784 shares), UBS Group AG (409,799 shares), Opaleye Management Inc. (389,519 shares), MILLENNIUM MANAGEMENT LLC (369,192 shares), NORTHERN TRUST CORP (259,597 shares), MORGAN STANLEY (222,193 shares), and JACOBS LEVY EQUITY MANAGEMENT, INC (138,199 shares).
This table shows the top 79 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.